Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net income $ 523 $ 1,104 $ 1,066
Less: Income from discontinued operations, net of tax (12) (49) (777)
Income from continuing operations 511 1,055 289
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (67) (143) (42)
Unrealized losses on fair value adjustments to Venator investment, net and related loss on disposal 12 28 88
Cash received from return on investment in unconsolidated subsidiary 71 57 19
Depreciation and amortization 281 278 267
Noncash lease expense 63 64 57
Gain on disposal of businesses/assets 0 (28) (281)
Loss on early extinguishment of debt 0 27 0
Noncash restructuring and impairment charges 6 18 7
Deferred income taxes 89 (39) 175
Stock-based compensation 29 30 26
Other, net (39) (11) 5
Changes in operating assets and liabilities:      
Accounts and notes receivable 146 (313) 99
Inventories (6) (342) 130
Receivable associated with the Albemarle Settlement 333 (333) 0
Other current assets (44) 39 (66)
Other noncurrent assets (52) (189) (55)
Accounts payable (84) 346 11
Accrued liabilities (304) 296 (132)
Taxes paid on Chemical Intermediates Businesses 0 0 (231)
Other noncurrent liabilities (53) 75 (135)
Net cash provided by operating activities from continuing operations 892 915 231
Net cash provided by operating activities from discontinued operations 22 37 22
Net cash provided by operating activities 914 952 253
Investing activities:      
Capital expenditures (272) (326) (237)
Cash received from sale of businesses 0 43 2,181
Acquisition of businesses, net of cash acquired 0 (245) (650)
Cash received from the sale of Venator shares 0 0 99
Proceeds from sale of assets 0 0 75
Insurance proceeds for recovery of property damage 5 8 0
Other 7 12 6
Net cash (used in) provided by investing activities from continuing operations (260) (508) 1,474
Net cash used in investing activities from discontinued operations (19) (16) (11)
Net cash (used in) provided by investing activities (279) (524) 1,463
Financing activities:      
Net borrowings (repayments) on revolving loan facilities 219 (8) (203)
Proceeds from issuance of long-term debt 0 447 0
Repayments of long-term debt (12) (990) (21)
Repayments of short-term debt 0 0 (109)
Repayments of notes payable 0 0 (32)
Costs of early extinguishment of debt 0 (26) 0
Dividends paid to common stockholders (171) (159) (144)
Distributions paid to noncontrolling interests (16) (40) (44)
Repurchase of common stock (1,005) (200) (96)
Repurchase and cancellation of stock awards (14) (7) (8)
Proceeds from issuance of common stock 6 10 3
Other (1) (4) (1)
Net cash used in financing activities (994) (977) (655)
Effect of exchange rate changes on cash (28) (3) 7
(Decrease) increase in cash and cash equivalents (387) (552) 1,068
Cash and cash equivalents from continuing operations at beginning of period 1,041 1,593 525
Cash and cash equivalents at end of period 654 1,041 1,593
Supplemental cash flow information:      
Cash paid for interest 66 82 90
Cash paid for income taxes 194 106 316
Huntsman International LLC [Member]      
Operating activities:      
Net income 524 1,107 1,067
Less: Income from discontinued operations, net of tax (12) (49) (777)
Income from continuing operations 512 1,058 290
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (67) (143) (42)
Unrealized losses on fair value adjustments to Venator investment, net and related loss on disposal 12 28 88
Cash received from return on investment in unconsolidated subsidiary 71 57 19
Depreciation and amortization 281 278 267
Noncash lease expense 63 64 57
Gain on disposal of businesses/assets 0 (28) (281)
Loss on early extinguishment of debt 0 27 0
Noncash restructuring and impairment charges 6 18 7
Deferred income taxes 91 (40) 175
Other, net (37) (13) 5
Noncash compensation 27 29 25
Changes in operating assets and liabilities:      
Accounts and notes receivable 146 (313) 99
Inventories (6) (342) 130
Receivable associated with the Albemarle Settlement 333 (333) 0
Other current assets (51) 47 (66)
Other noncurrent assets (52) (189) (55)
Accounts payable (84) 343 9
Accrued liabilities (297) 292 (132)
Taxes paid on Chemical Intermediates Businesses 0 0 (231)
Other noncurrent liabilities (53) 78 (131)
Net cash provided by operating activities from continuing operations 895 918 233
Net cash provided by operating activities from discontinued operations 22 37 22
Net cash provided by operating activities 917 955 255
Investing activities:      
Capital expenditures (272) (326) (237)
Cash received from sale of businesses 0 43 2,181
Acquisition of businesses, net of cash acquired 0 (245) (650)
Cash received from the sale of Venator shares 0 0 99
Proceeds from sale of assets 0 0 75
Insurance proceeds for recovery of property damage 5 8 0
Other 7 13 7
Net cash (used in) provided by investing activities from continuing operations (1,277) (710) 1,748
Net cash used in investing activities from discontinued operations (19) (16) (11)
Net cash (used in) provided by investing activities (1,296) (726) 1,737
(Increase) decrease in receivable from affiliate (1,017) (203) 273
Financing activities:      
Net borrowings (repayments) on revolving loan facilities 219 (8) (203)
Proceeds from issuance of long-term debt 0 447 0
Repayments of long-term debt (12) (990) (21)
Repayments of short-term debt 0 0 (109)
Repayments of notes payable 0 0 (32)
Costs of early extinguishment of debt 0 (26) 0
Distributions paid to noncontrolling interests (16) (40) (44)
Other (1) (3) 0
Net cash used in financing activities 22 (778) (933)
Effect of exchange rate changes on cash (28) (3) 7
(Decrease) increase in cash and cash equivalents (385) (552) 1,066
Cash and cash equivalents from continuing operations at beginning of period 1,039 1,591 525
Cash and cash equivalents at end of period 654 1,039 1,591
Repayments of notes payable to affiliate 0 0 (380)
Dividends paid to parent (168) (158) (144)
Supplemental cash flow information:      
Cash paid for interest 66 82 90
Cash paid for income taxes $ 194 $ 106 $ 316